Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients [NA]

View source ↗

Summary

The update describes ongoing safety considerations for using lower scalp cooling temperatures to prevent chemotherapy-induced hair loss in breast cancer patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Breast Cancer Stage I | NA | Status: ACTIVE_NOT_RECRUITING